Aims and scope
Bioelectronic Medicine is an open access journal that focuses on the scientific discipline which brings together molecular medicine, bioengineering, and neuroscience, to discover and develop nerve stimulating and sensing technologies to diagnose and regulate biological processes and treat disease. The journal also features bioelectronic approaches for monitoring and controlling biological mechanisms and host and pathogen physiology. It provides bioelectronic insights into disease pathogenesis, treating paralysis, restoration of musculoskeletal function and mobility, prostheses, robotics, and other areas. Read more.
About the Editor
Dr Kevin J Tracey is president of The Feinstein Institute for Medical Research, and professor of Molecular Medicine and Neurosurgery at the Zucker School of Medicine. He is a leader in the study of the molecular basis of inflammation. He and his colleagues identified the neural mechanism for controlling the immunological responses to infection and injury, and developed devices to replace anti-inflammatory drugs in clinical trials of rheumatoid arthritis, a new field termed bioelectronic medicine. The recipient of numerous awards and honors, including an honorary degree from the Karolinska Institutet, Dr Tracey is a fellow in the American Association for the Advancement of Science, and a member in the American Society for Clinical Investigation, and the Association of American Physicians. He is co-founder and Councilor of the Global Sepsis Alliance.
Dr Tracey graduated summa cum laude from Boston College, majoring in chemistry, and received his MD from Boston University. He trained in neurosurgery at the New York Hospital/Cornell University Medical Center, and was guest investigator at The Rockefeller University. Since 1992, he has directed the Laboratory of Biomedical Science in Manhasset, NY, where in 2005 he was appointed president of the Feinstein Institute. Dr Tracey delivers lectures nationally and internationally on inflammation, sepsis, the neuroscience of immunity, and bioelectronic medicine. He is the author of Fatal Sequence (Dana Press) and more than 370 scientific papers.
About Feinstein Institute for Medical Research
Bioelectronic Medicine is published in partnership with The Feinstein Institute for Medical Research. As the research arm of Northwell Health, the largest healthcare provider in New York, it is home to 50 research laboratories and to clinical research throughout dozens of hospitals and outpatient facilities. The Feinstein Institute includes 4,000 researchers and staff who are making breakthroughs in molecular medicine, genetics, oncology, brain research, mental health, autoimmunity, and bioelectronic medicine – a new field of science that has the potential to revolutionize medicine. For more information about how the Feinstein Institute empowers imagination and pioneers discovery, visit FeinsteinInstitute.org.
From the blog
15 March 2018
15 March 2018
Annual Journal Metrics
40 days to first decision for reviewed manuscripts only
40 days to first decision for all manuscripts
74 days from submission to acceptance
24 days from acceptance to publication